OxyContin maker Purdue Pharma's plan to reorganize into an entity whose profits will be used to combat the U.S. opioid crisis got a big boost as 15 states dropped their objections to the new business model. (July 8)

Subscribe for more Breaking News: http://smarturl.it/AssociatedPress
Website: https://apnews.com
Twitter: https://twitter.com/AP
Facebook: https://facebook.com/APNews
Instagram: https://www.instagram.com/APNews/
​

You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/0f27959ba63f4500b72ccaed8b860e5d